Market Scenario:
Immunoassay analyzer is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzer market size is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. An immunoassay is a biochemical test that measures the presence or concentration of analytes or antibodies. Immunoassays have been widely used in many important areas of pharmaceutical analysis such as diagnosis of diseases, therapeutic drug monitoring, clinical pharmacokinetic and bioequivalence studies in drug discovery and pharmaceutical industries. The importance and widespread of immunoassay methods in pharmaceutical analysis are attributed to their inherent specificity, high-throughput, and high sensitivity for the analysis of wide range of analytes in biological samples
Market Segmentation:
The global immunoassay analyzer market is segmented on the basis of instruments, applications, and end users.
On the basis of instruments, the market is classified into immunofluorescence, chemiluminescence, ELISA, enzyme linked fluorescent system, multiplexed assay system, radioimmunoassay and others.
On the basis of application, the market is segmented into infectious diseases, autoimmune diseases, AIDS, endocrinology, drug monitoring, cardiology, oncology, allergy testing and others.
On the basis of end users, the market is categorized into hospitals, diagnostic laboratories, research institutes, and others.
Regional Analysis:
The global immunoassay analyzer market is dominated by America, which is followed by Europe. Presence of huge diabetic and cancer population, large geriatric population, and well developed healthcare sector has driven this market’s growth in America. Europe immunoassay companies is majorly driven by the presence of large number of pharmaceutical and biotechnological companies. Along with these, Asia Pacific also has the fastest growing immunoassay analyzer market due to rapidly developing economies with huge population base, mainly in India and China. However, the Middle East & Africa has the least market due to limited development in the healthcare sector.
Competitive Overview:
Some of the major key player of this market are F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Ltd. (Germany), Abbott (US), Beckman Coulter, Inc. (US), Ortho Clinical Diagnostics (US), bioMérieux Private Limited (France), Biokit S.A (Spain), The Binding Site Group Ltd. (UK), Immunodiagnostic Systems (UK), Merck KGaA (US), Olympus Corporation (Japan), Nova Century Scientific, Inc. (US), Thermo Fisher Scientific (US), DiaSorin S.p.A. (Italy), and Randox Laboratories Ltd. (UK) Increasing prevalence of different types of chronic diseases is fueling the growth of this market. The global immunoassay analyzer market is a highly competitive market due to the presence of many small and medium companies. These companies are focusing on the development of new and advances devices, while some companies have adopted strategies of acquisitions and strategic alliances, this will consequently lead to this market’s growth.
Hoffmann-La Roche Ltd, a Swiss multinational healthcare company, operates under two division, which are diagnostics and pharmaceuticals. In 2016, the company launched the new cobas e 801 module, which will help hospitals and laboratories to meet the demand of diagnostic testing. Cobas e 602 is one of the most widely used devices of this company.
Beckman Coulter, Inc., headquartered in California, US, is a manufacturer of biomedical laboratory instruments. In 2015, the company completed the acquisition of MicroScan from Siemens Healthcare. UniCel DxI 800, UniCel DxI 600, and Access 2 are some of the major immunoassay analyzer manufactured by this company.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
